Potassium orotate, tablets 500 mg 30 pcs

As part of the combined therapy:

• liver and biliary tract diseases caused by intoxication (except cirrhosis with ascites);
• myocardial infarction and chronic heart failure stages II and III;
• cardiac rhythm disorders (especially extrasystole and atrial fibrillation;
• dermatoses;
• alimentary and alimentary-infectious hypotrophy in children, progressive muscular dystrophy.

Reconvalescence period, increased physical activity.

Active ingredient

Orotic acid

Composition

1 potassium orotate tablet 0.5 g

Directions for use

Orally administered by 250-500 mg 2-3 times daily 1 hour before a meal or 4 hours after a meal.

Contraindications

• Hepatic cirrhosis with ascites,
• nephrourolithiasis,
• chronic renal failure,
• high sensitivity to orotic acid.

.